Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologs

Interleukin-5 (IL-5) is a key mediator of eosinophilic inflammation. The biological role of this cytokine in an allergic airway inflammatory response has been widely demonstrated in guinea pigs, yet the interaction of guinea pig IL-5 (gpIL-5) with its receptor has not been studied. Experiments were...

Full description

Bibliographic Details
Main Authors: Clay W Scott, Carol Budzilowicz, Stephen J. Hubbs, Mark Stein, Cindy Sobotka-Briner, Deidre E. Wilkins
Format: Article
Language:English
Published: Hindawi Limited 2000-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1080/09629350020008709
id doaj-506cbc3752cb46b4be4b3a775579f67a
record_format Article
spelling doaj-506cbc3752cb46b4be4b3a775579f67a2020-11-25T01:28:35ZengHindawi LimitedMediators of Inflammation0962-93511466-18612000-01-0193-418118710.1080/09629350020008709Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologsClay W Scott0Carol Budzilowicz1Stephen J. Hubbs2Mark Stein3Cindy Sobotka-Briner4Deidre E. Wilkins5AstraZeneca Pharmaceuticals, CNS Discovery Research, LW208, 1800 Concord Pike, Wilmington 19810, DE, USAAstraZeneca Pharmaceuticals, CNS Discovery Research, LW208, 1800 Concord Pike, Wilmington 19810, DE, USAAstraZeneca Pharmaceuticals, CNS Discovery Research, LW208, 1800 Concord Pike, Wilmington 19810, DE, USAAstraZeneca Pharmaceuticals, CNS Discovery Research, LW208, 1800 Concord Pike, Wilmington 19810, DE, USAAstraZeneca Pharmaceuticals, CNS Discovery Research, LW208, 1800 Concord Pike, Wilmington 19810, DE, USAAstraZeneca Pharmaceuticals, CNS Discovery Research, LW208, 1800 Concord Pike, Wilmington 19810, DE, USAInterleukin-5 (IL-5) is a key mediator of eosinophilic inflammation. The biological role of this cytokine in an allergic airway inflammatory response has been widely demonstrated in guinea pigs, yet the interaction of guinea pig IL-5 (gpIL-5) with its receptor has not been studied. Experiments were performed to quantitate the interaction of gpIL-5 with gpIL-5r and to compare this affinity with that of hIL-5 and mIL-5 and their cognate receptors. The cross-species affinity and agonist efficacy were evaluated to see if gpIL-5r had a restricted species reactivity (as is the case with mIL-5r) or did not distinguish between IL-5 orthologs (similar to hIL-5r). gpIL-5 was cloned using mRNA isolated from cells obtained by bronchoalveolar lavage. Recombinant gpIL-5 was expressed in T.ni insect cells and purified from spent media. Binding assays were performed using insect cells expressing hIL-5rαβ or gpIL-5rαβ1 as previously described (Cytokine, 12:858–866, 2000) or using B13 cells which express mIL-5r. The agonist potency and efficacy properties of each IL-5 ortholog were evaluated by quantitating the proliferative response of hum an TF-1 cells and murine B13 cells. gpIL-5 bound with high affinity to recombinant gpIL-5r as demonstrated by displacing [125I]hIL-5 (Ki = 160 pM). gpIL-5 also bound to hIL-5r with high affinity (Ki = 750 pM). hIL-5 and mIL-5 showed similar, high-affinity binding profiles to both gpIL-5r and hIL-5r. In contrast, gpIL-5 and hIL5 did not bind to the mIL-5r as demonstrated by an inability to displace [125I]mIL-5, even at 1000-fold molar excess. These differences in affinity for IL-5r orthologs correlated with bioassay results: human TF1 cells showed roughly com parable proliferative responses to guinea pig, hum an and murine IL-5 whereas murine B13 cells showed a strong preference for murine over guinea pig and human IL-5(EC50 = 1.9, 2200 and 720 pM, respectively). Recombinant gpIL-5 binds to the gpIL-5r with high affinity, similar to that seen with the human ligand-receptor pair. gpIL-5r and hIL-5r do not distinguish between the three IL-5 orthologs whereas mIL-5r has restricted specificity for its cognate ligand.http://dx.doi.org/10.1080/09629350020008709
collection DOAJ
language English
format Article
sources DOAJ
author Clay W Scott
Carol Budzilowicz
Stephen J. Hubbs
Mark Stein
Cindy Sobotka-Briner
Deidre E. Wilkins
spellingShingle Clay W Scott
Carol Budzilowicz
Stephen J. Hubbs
Mark Stein
Cindy Sobotka-Briner
Deidre E. Wilkins
Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologs
Mediators of Inflammation
author_facet Clay W Scott
Carol Budzilowicz
Stephen J. Hubbs
Mark Stein
Cindy Sobotka-Briner
Deidre E. Wilkins
author_sort Clay W Scott
title Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologs
title_short Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologs
title_full Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologs
title_fullStr Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologs
title_full_unstemmed Expression and in vitro properties of guinea pig IL-5: Comparison to human and murine orthologs
title_sort expression and in vitro properties of guinea pig il-5: comparison to human and murine orthologs
publisher Hindawi Limited
series Mediators of Inflammation
issn 0962-9351
1466-1861
publishDate 2000-01-01
description Interleukin-5 (IL-5) is a key mediator of eosinophilic inflammation. The biological role of this cytokine in an allergic airway inflammatory response has been widely demonstrated in guinea pigs, yet the interaction of guinea pig IL-5 (gpIL-5) with its receptor has not been studied. Experiments were performed to quantitate the interaction of gpIL-5 with gpIL-5r and to compare this affinity with that of hIL-5 and mIL-5 and their cognate receptors. The cross-species affinity and agonist efficacy were evaluated to see if gpIL-5r had a restricted species reactivity (as is the case with mIL-5r) or did not distinguish between IL-5 orthologs (similar to hIL-5r). gpIL-5 was cloned using mRNA isolated from cells obtained by bronchoalveolar lavage. Recombinant gpIL-5 was expressed in T.ni insect cells and purified from spent media. Binding assays were performed using insect cells expressing hIL-5rαβ or gpIL-5rαβ1 as previously described (Cytokine, 12:858–866, 2000) or using B13 cells which express mIL-5r. The agonist potency and efficacy properties of each IL-5 ortholog were evaluated by quantitating the proliferative response of hum an TF-1 cells and murine B13 cells. gpIL-5 bound with high affinity to recombinant gpIL-5r as demonstrated by displacing [125I]hIL-5 (Ki = 160 pM). gpIL-5 also bound to hIL-5r with high affinity (Ki = 750 pM). hIL-5 and mIL-5 showed similar, high-affinity binding profiles to both gpIL-5r and hIL-5r. In contrast, gpIL-5 and hIL5 did not bind to the mIL-5r as demonstrated by an inability to displace [125I]mIL-5, even at 1000-fold molar excess. These differences in affinity for IL-5r orthologs correlated with bioassay results: human TF1 cells showed roughly com parable proliferative responses to guinea pig, hum an and murine IL-5 whereas murine B13 cells showed a strong preference for murine over guinea pig and human IL-5(EC50 = 1.9, 2200 and 720 pM, respectively). Recombinant gpIL-5 binds to the gpIL-5r with high affinity, similar to that seen with the human ligand-receptor pair. gpIL-5r and hIL-5r do not distinguish between the three IL-5 orthologs whereas mIL-5r has restricted specificity for its cognate ligand.
url http://dx.doi.org/10.1080/09629350020008709
work_keys_str_mv AT claywscott expressionandinvitropropertiesofguineapigil5comparisontohumanandmurineorthologs
AT carolbudzilowicz expressionandinvitropropertiesofguineapigil5comparisontohumanandmurineorthologs
AT stephenjhubbs expressionandinvitropropertiesofguineapigil5comparisontohumanandmurineorthologs
AT markstein expressionandinvitropropertiesofguineapigil5comparisontohumanandmurineorthologs
AT cindysobotkabriner expressionandinvitropropertiesofguineapigil5comparisontohumanandmurineorthologs
AT deidreewilkins expressionandinvitropropertiesofguineapigil5comparisontohumanandmurineorthologs
_version_ 1725100674473000960